BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36797496)

  • 1. Disparities in pediatric drug-resistant epilepsy care.
    LoPresti MA; Zhang L; Lam S
    Childs Nerv Syst; 2023 Jun; 39(6):1611-1617. PubMed ID: 36797496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term survival with continued medical therapy, vagus nerve stimulation, and cranial epilepsy surgery in paediatric patients with drug-resistant epilepsy in the USA: an observational cohort study.
    Zhang L; Hall M; Lam SK
    Lancet Child Adolesc Health; 2023 Jul; 7(7):455-462. PubMed ID: 37276875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital costs associated with vagus nerve stimulation and medical treatment in pediatric patients with refractory epilepsy.
    Zhang L; Hall M; Lam SK
    Epilepsia; 2022 May; 63(5):1141-1151. PubMed ID: 35188675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of social determinants of health on utilization of pediatric epilepsy surgery: a systematic review.
    Winterhalter E; LoPresti MA; Widjaja E; Mohapatra A; Shlobin NA; Zhang L; Lam S
    J Neurosurg Pediatr; 2024 Jul; 34(1):30-39. PubMed ID: 38579357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
    Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative evaluation and surgical management of infants and toddlers with drug-resistant epilepsy.
    Pindrik J; Hoang N; Smith L; Halverson M; Wojnaroski M; McNally K; Gedela S; Ostendorf AP
    Neurosurg Focus; 2018 Sep; 45(3):E3. PubMed ID: 30173613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
    Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal EpiTrack assessment of executive functions following vagus nerve stimulation therapy in patients with drug-resistant epilepsy.
    Lähde N; Basnyat P; Raitanen J; Lehtimäki K; Rosti-Otajärvi E; Peltola J
    Epilepsia Open; 2024 Feb; 9(1):150-163. PubMed ID: 37897151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology.
    Xie H; Ma J; Ji T; Liu Q; Cai L; Wu Y
    Epilepsy Behav; 2023 Mar; 140():109107. PubMed ID: 36758359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underutilization of advanced presurgical studies and high rates of vagus nerve stimulation for drug-resistant epilepsy: a single-center experience and recommendations.
    Solli E; Colwell NA; Markosian C; Johal AS; Houston R; Iqbal MO; Say I; Petrsoric JI; Tomycz LD
    Acta Neurochir (Wien); 2022 Feb; 164(2):565-573. PubMed ID: 34773497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of anti-seizure medication (ASM) use in pediatric patients with surgically managed epilepsy: A retrospective review of data from Boston Children's Hospital.
    Wang S; Rotenberg A; Bolton J
    Epilepsy Res; 2020 Feb; 160():106257. PubMed ID: 32004867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a clinical model to predict vagus nerve stimulation response in pediatric patients with drug-resistant epilepsy.
    Muthiah N; Mallela AN; Vodovotz L; Sharma N; Akwayena E; Pan E; Welch W; Ibrahim GM; Abel TJ
    J Neurosurg Pediatr; 2023 May; 31(5):476-483. PubMed ID: 36805960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis.
    Batson S; Shankar R; Conry J; Boggs J; Radtke R; Mitchell S; Barion F; Murphy J; Danielson V
    J Neurol; 2022 Jun; 269(6):2874-2891. PubMed ID: 35034187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior Nucleus of the Thalamus Deep Brain Stimulation with Concomitant Vagus Nerve Stimulation for Drug-Resistant Epilepsy.
    Parisi V; Lundstrom BN; Kerezoudis P; Alcala Zermeno JL; Worrell GA; Van Gompel JJ
    Neurosurgery; 2021 Sep; 89(4):686-694. PubMed ID: 34333659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Standardized Mortality Ratio and Utilization of Care in US Veterans With Drug-Resistant Epilepsy Compared With All US Veterans and the US General Population.
    Haneef Z; Rehman R; Husain AM
    JAMA Neurol; 2022 Sep; 79(9):879-887. PubMed ID: 35969384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the effectiveness of vagus nerve stimulation for pediatric drug-resistant epilepsies secondary to nonaccidental trauma.
    Muthiah N; Joseph B; Varga G; Vodovotz L; Sharma N; Abel TJ
    Childs Nerv Syst; 2023 May; 39(5):1201-1206. PubMed ID: 36602582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of healthcare resource utilization in pediatric patients with refractory epilepsy: Vagus nerve stimulation and medical treatment cohorts.
    Zhang L; Wu JY; Lam SK
    Epilepsy Behav; 2021 Oct; 123():108281. PubMed ID: 34509035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of vagus nerve stimulation in refractory pediatric epilepsy: A single-center experience.
    Yalnizoglu D; Ardicli D; Bilginer B; Konuskan B; Karli Oguz K; Akalan N; Turanli G; Saygi S; Topcu M
    Epilepsy Behav; 2020 Sep; 110():107147. PubMed ID: 32604021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.